Buda Juice Stock Rallies After Roth/MKM Initiates Coverage with 'Buy' Rating

Shares of Buda Juice Inc. (BUDA) rallied on Monday, bucking a broader market downturn after investment firm Roth/MKM initiated coverage on the stock with a bullish outlook.

The stock gained nearly 4.9% in mid-day trading, a significant counter-trend move as major indices like the S&P 500, Dow Jones, and Nasdaq were all down between 0.7% and 1.0% during the session.

Analyst Cites Expansion Potential

Roth/MKM analyst George Kelly started coverage of Buda Juice with a Buy rating and a $12.00 price target. According to the analyst, the positive thesis is built on several key factors:

• A differentiated, end-to-end cold supply chain for its fresh, unpasteurized products.
• Strong sales velocities already demonstrated in its home market of Texas.
• A competitive position in an "uncrowded niche" within the produce sections of major grocery retailers.
• The availability of post-IPO capital to fund the replication of its successful "Texas playbook" in new geographic markets.

Ad

The initiation from Roth/MKM marks the first significant Wall Street coverage of the company in recent months, providing investors with a new framework for valuing its growth prospects.

Market Context

The $12.00 price target is notable as it aligns with the stock's 52-week high, suggesting the firm sees a path for a full recovery. Prior to Monday's rally, Buda Juice shares had underperformed, trading closer to their 52-week low of $6.25.

Today's company-specific momentum, driven by the new analyst coverage, allowed the stock to trade sharply higher despite widespread weakness in the equity markets. The combination of a credible expansion narrative and a stock trading well below its prior peak created the conditions for the strong investor response.